ATGE — Adtalem Global Education Inc.

Adtalem Global Education (ATGE) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: Increased by 10.8% year-over-year to $462.3 million.
• Adjusted EBITDA: Rose 15.8% to $112 million, with an adjusted EBITDA margin of 24.2%, up 100 basis points.
• Adjusted Earnings Per Share (EPS): Increased by 35.7% to $1.75.
• Total Enrollment: Up 8% year-over-year to 97,000 students.
• Free Cash Flow: Generated $319 million over the trailing 12 months.
• Cash and Equivalents: $265 million as of September 30.
• Share Repurchase: $8 million in shares repurchased, with $142 million remaining in the buyback program.

2. Strategic Updates and Business Highlights

• Enrollment Growth: Marked the ninth consecutive quarter of enrollment growth across the company.
  • Walden University: Enrollment grew by 13.6%, achieving a record total of over 52,000 students.
  • Chamberlain University: Enrollment increased by 2.2%, but growth was below expectations due to marketing execution issues.
  • Medical and Veterinary Segment: Enrollment up 2.4%, with Ross Med achieving its largest new student start in five years.
• Partnerships: New strategic partnerships include collaborations with Google Cloud for AI training and with ScribeAmerica to create pathways for healthcare workers to medical school.
• Operational Improvements: Focused on enhancing marketing effectiveness and streamlining enrollment processes at Chamberlain.

3. Forward Guidance and Outlook

• Full Year Guidance: Maintained revenue guidance of $1.9 billion to $1.94 billion and adjusted EPS of $7.60 to $7.90.
• Anticipated Challenges: Expected softness in post-licensure enrollment through Q2 and Q3 due to recent execution issues but confident in recovery in the latter half of the fiscal year.
• Investor Day: Scheduled for February 24, 2026, to discuss strategic roadmaps and long-term value creation.

4. Bad News, Challenges, or Points of Concern

• Chamberlain Performance: Enrollment growth fell short of expectations due to marketing missteps and lower conversion rates, leading to a decline in adjusted EBITDA margin to 19.6%.
• Execution Issues: Identified problems in local marketing effectiveness and enrollment funnel conversion, which are being addressed but may impact short-term performance.
• Market Dynamics: Concerns about the broader healthcare workforce crisis and potential impacts from increased regulatory scrutiny on enrollment processes.

5. Notable Q&A Insights

• Chamberlain Enrollment Outlook: Management expressed confidence that recent challenges are not indicative of a long-term trend and expect recovery as operational improvements take effect.
• Technology Infrastructure: Assured that their technology systems are robust and not experiencing issues similar to competitors, emphasizing confidence in their operational capabilities.
• Partnership with Sallie Mae: Updates on the partnership are forthcoming, with expectations to finalize documentation soon.
• Regulatory Environment: No significant increase in fraudulent enrollments noted, and management believes recent regulatory changes will not adversely affect their enrollment figures.

Overall, while Adtalem Global Education reported strong financial growth and strategic initiatives, challenges at Chamberlain University regarding enrollment execution were highlighted as a key area of focus moving forward.